The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

CVS Health (CVS) closed the most recent trading day at $61.96, moving -2.12% from the previous trading session. This change lagged the S&P 500's 0.01% loss on the day. Elsewhere, the Dow lost 0.32%, ...

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors ...

Goldman Sachs stock rises 20% YTD, outpacing the S&P 500. Analysts suggest holding GS due to its high momentum but caution on ...

Woonsocket, Rhode Island-based CVS Health Corporation (CVS) offers a comprehensive range of healthcare solutions, including pharmacy benefit management services, mail-order pharmacies, retail ...

For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

For 2025, Barclays estimates market forecasts include expectations of 110 basis points in Medicare margin expansion, which is on the lower end of CVS’s target range of 100-200 bps.

That shows the power of CVS’ market saturation; it pushed Hyrimoz through every arm of its business. CVS said the list price of Hyrimoz is 81% cheaper than brand-name Humira.

CVS Health (CVS) closed at $67.58 in the latest trading session, marking a +1.15% move from the prior day. This move outpaced the S&P 500's daily gain of 1.11%. Elsewhere, the Dow gained 1.19% ...

In the latest market close, CVS Health (CVS) reached $59.06, with a +1.2% movement compared to the previous day. This move outpaced the S&P 500's daily loss of 0.41%. Elsewhere, the Dow lost 0.12% ...

CVS Health Corp. is on track to shed roughly a fifth of its market value with a daily stock slide not seen in almost 15 years. Shares are off 19.5% in morning trading Wednesday. That puts them on ...